De La Cruz Sulfur Acne Medication

Manufacturer
DLC Laboratories, Inc.
Effective date
2024-10-10
Label type
HUMAN OTC DRUG LABEL
Version
9
Source
legacy-cache
Hydrated at
2026-08-01 20:52:55

Label at a glance#

ProductDe La Cruz Sulfur Acne Medication
Active ingredientSULFUR
Label structure10 sections

Indications and uses

for the treatment of acne penetrates the pores and dries and clears acne pimples and blackheads helps to keep new acne pimples and blackheads from forming

Dosage and administration

cleanse the skin thoroughly before applying cover the entire affected area with a thin layer leave on for 10 minutes thoroughly remove with water because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Sulfur, 10%

Purpose

OTC - PURPOSE SECTION

Acne medication

Uses

INDICATIONS & USAGE SECTION

for the treatment of acne

  • penetrates the pores and dries and clears acne pimples and blackheads
  • helps to keep new acne pimples and blackheads from forming

Warnings

WARNINGS SECTION

For external use only

Do not use on

OTC - DO NOT USE SECTION

  • broken skin
  • large areas of the skin

When using this product

OTC - WHEN USING SECTION

  • do not get into eyes
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time or right after use of this product. If irritation occurs, only use one topical acne medication at a time.
  • apply only to areas with acne

OTC - STOP USE SECTION

Stop use and consult a doctor if excessive skin irritation develops or increases.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • cleanse the skin thoroughly before applying
  • cover the entire affected area with a thin layer
  • leave on for 10 minutes
  • thoroughly remove with water
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Inactive ingredient

INACTIVE INGREDIENT SECTION

polyethylene glycol

Questions?

OTC - QUESTIONS SECTION

1-800-858-3889

SPL UNCLASSIFIED SECTION

Manufactured by:
De La Cruz Products
A Division of DLC Laboratories, Inc.
Paramount, CA 90723 USA

PRINCIPAL DISPLAY PANEL - 73.7 g Jar Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

De La Cruz ®

MAXIMUM STRENGTH

SULFUR
OINTMENT
10%

Acne Medication

2.6 OZ (73.7 g)

PRINCIPAL DISPLAY PANEL - 73.7 g Jar Label
PRINCIPAL DISPLAY PANEL - 73.7 g Jar Label

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
SULFURACTIVE INGREDIENT70FD1KFU704
SULFURACTIVE MOIETY70FD1KFU704
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
24286-152524286-1525-2, 24286-1525-3, 24286-1525-4

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
POLYETHYLENE GLYCOL, UNSPECIFIED3WJQ0SDW1AIACT
SULFUR70FD1KFU70ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
34b9271a-0ea1-d8b6-e063-6294a90ad18fc00d53c4-a150-411f-acd7-4ffb8a35d4492025-05-09WarningsExact identifier
spl set id: c00d53c4-a150-411f-acd7-4ffb8a35d449

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.